These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Inflammatory myopathies]. Cherin P. Rev Prat; 2001 Feb 15; 51(3):270-7. PubMed ID: 11265423 [Abstract] [Full Text] [Related]
4. Inclusion body myositis: clinical and pathological boundaries. Amato AA, Gronseth GS, Jackson CE, Wolfe GI, Katz JS, Bryan WW, Barohn RJ. Ann Neurol; 1996 Oct 15; 40(4):581-6. PubMed ID: 8871577 [Abstract] [Full Text] [Related]
5. Current Classification and Management of Inflammatory Myopathies. Schmidt J. J Neuromuscul Dis; 2018 Oct 15; 5(2):109-129. PubMed ID: 29865091 [Abstract] [Full Text] [Related]
10. Dermatomyositis, polymyositis and inclusion body myositis: current concepts. Illa I, Dalakas MC. Rev Neurol (Paris); 1998 Jan 15; 154(1):13-6. PubMed ID: 9773019 [No Abstract] [Full Text] [Related]
11. mTOR is expressed in polymyositis but not in sporadic inclusion body myositis. Panaite PA, Stalder AK, Ipsen S, Kuntzer T, Steck AJ. Clin Neuropathol; 2015 Jan 15; 34(6):371-3. PubMed ID: 26104108 [No Abstract] [Full Text] [Related]